Latest News and Press Releases
Want to stay updated on the latest news?
-
Top liver disease conference showcases positive clinical data from Yaqrit’s technologies Results from two trials presented at EASL1 International Liver Conference 2021 show benefits for patients...
-
Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure Orally-administered, non-absorbable engineered...
-
Yaqrit as part of the ALIVER Consortium announces completion of first randomised controlled study of DIALIVE for ACLF at EASL’s Digital International Liver Congress Data from study to be...